2019第四届亚太医疗政策峰会 产业会议
会议标题 2019第四届亚太医疗政策峰会
会议时间 2019-05-10 到 2019-05-11
会议地点 新加坡
官方网址

4th Healthcare Policy Asia Pacific Summit 2019

2019第四届亚太医疗政策峰会


May 9-10, 2019 • Singapore


About 

关于


About this Event


Why attend HAP4? (event background)


The market for healthcare in the Asia Pacific region expanded at more than a 12% CAGR from 2012 to 2018, and strong growth is projected for the near future. With continued population growth, increased disposable incomes, and rapid urbanization, the Asia Pacific region is ripe with opportunity for global healthcare providers. However, as government policies and market conditions across the region differ substantially from those of the European and American markets, the continued development of the healthcare industry faces a set of unique challenges.


The 4th Asia Pacific Healthcare Summit 2019 will provide attendees with detailed information on the latest regulatory policies for healthcare across the Asia Pacific region, and offer a platform for healthcare industry professionals to share experiences, and express opinions on optimal business practices in the wake of changes within the industry.


What you will learn (highlights)

-More than 100 Delegates interpreting healthcare regulations in Singapore, Japan, South Korea, Thailand, India, Vietnam, and other major jurisdictions

-Firsthand testimony from government officials and industry leaders on healthcare policy in the APAC region and around the world, as well as future market trends

-Detailed look at the registration process and market access strategy for healthcare products.

-The latest knowledge on quality assurance and regulatory compliance for medical devices and pharmaceuticals

-In-depth analysis of product development and clinical trial requirements in the Asia Pacific region

-Information on cutting-edge innovationintegrating drugs with medical devices

-Challenges and opportunities for medical device supply chains and distributors

-Robust exchange between company representatives and government regulators, in the interest of developing the industry


Speakers   

演讲嘉宾


Speakers to Invite

Health Sciences Authority (HSA), Singapore

The Ministry of Food and Drug Safety (MFDS), Korea 

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

The Therapeutic Goods Administration (TGA), Australia

Food and Drug Administration (FDA), Thailand

Ministry of Health Vietnam

Ministry of Health Malaysia

Ministry of Health & Family Welfare (MOHFW), India 

World Health Organization (WHO)

The ASEAN Secretariat

Leading International Healthcare Companies


Attendees    

参会嘉宾


Who should attend?

By Industry 

• Pharmaceutical Companies

• Medical Device Companies

• Medical Merchandising

• Law Firm/Advisor Consulting

• Medical Services

• Insurance Companies

By Job Title

• Top Management

• Government Affairs Director/Manager

• Regulatory Affairs Director/Manager

• Registration Director/Manager

• Quality Assurance/ Compliance

• Medical Affairs Director/Manager

• Business & Marketing Director/Manager

• Public Relations Director/Manager

• External/Corporate Affairs Director/ Manager

• Legal Director/Manager


Some Previous Attendees 


3M Asia Pacific Pte Ltd.

Baxter International Inc.-Baxalta

Allergan Inc.

Aspen Pharmacare Holdings Limited

SANOFI PASTEUR

Astrazeneca

St. Jude Medical

Ipsen

Borouge

C. R. Bard

Bayer Healthcare

Fresenius Medical Care Asia- Pacific Ltd.

GSK (GlaxoSmithKline Pte Ltd)

Takeda Pharmaceutical Company Limited

Janssen Pharmaceuticals, Inc. Johnson & Johnson

Johnson & Johnson

Medtronic, Inc. 

Merck

MSD International

Sanofi

Mundipharma International

Philips

Linde Gas Asia Pte Ltd.

Novartis Asia Pacific Pharmaceuticals Pte Ltd.

Kimberly-Clark Health Care_ Halyard

Hologic, Inc.

Air Liquide (China) Holding Co., Ltd.

Cordis (Shanghai) Medical Devices Co., Ltd.

Shire Pharmaceuticals Group plc

Illumina

SchlafenderHase

SERVIER

Thermo Fisher Scientific Inc

Teva Pharmaceutical Industries Ltd.

Viveve

Baker & McKenzie

Beckman Coulter Danaher (Danaher Bernstein)

Biogen Idec

B. Braun Medical Industries SdnBhd

Cook South East Asia

Connexall


Schedule 

日程


Event Schedule


Thursday

May 9, 2019


Regulatory & Policy Environment in APAC Jurisdictions


Friday

May 10, 2019

Market Access and Regulatory Compliance

Clinical Trials and New Product Development

Procurement and Allocation

Quality Assurance and Quality Control


For further information, please contact:

Ms. Cindy CUI

Tel: + 86215258 8005 Ext. 8253


广告
游客需要先 登录 才能评论
评论(0)
暂无评论
独家报道
9月19日,安徽省药品招采部门在合肥召开医药企业座谈会,会议...
8小时前 阅读: 1647
一周医药行业大事盘点概况
9小时前 阅读: 1697
一周药品审核审评专题,透彻了解医药行业新动态。
9小时前 阅读: 1705
截止9月19日,CDE受理一致性评价受理号达1441个;已过...
3天前 阅读: 5272
恩替卡韦,作为抗乙肝一线药物被我们所熟识,但如果说真正意义上...
3天前 阅读: 5667
2018年国内样本医院销售额达到了190.70亿元,同比增长...
4天前 阅读: 6479
由中国医药城主办、药智网承办、泰州医药高新区高层次人才联谊会...
5天前 阅读: 6786
第十届中国(泰州)国际医药博览会于9月18日隆重开幕,会上中...
5天前 阅读: 6780
8月美国与欧洲审批上市新药到底有哪些,又有哪些成分需要集中审...
5天前 阅读: 6456
热门推荐
发展“智造”业务,其目标市场或不止高通量测序,
8小时前 阅读: 580
山东宣布集采挂网产品开始价格联动。
4天前 阅读: 2468
今年以来,阿达木单抗注射液(修美乐)在全国多地传来降价消息。
4天前 阅读: 2432
今天是国家医保局成立的第552天!
5天前 阅读: 1650
本周38个报生产受理号(29个品种)审批审批办理状态更新。新...
6天前 阅读: 2505
2019中国国际实验室规划、建设与管理大会(labtech ...
2星期前 阅读: 2714
近日,正大天晴以新4类提交马昔腾坦仿制药上市申请。
1星期前 阅读: 3249
国家医保局答复胡季强等11位全国人大代表关于完善公立医院药品...
1星期前 阅读: 2933
异地就医医保支付或将不再是难事儿。
1星期前 阅读: 3148
医院销售数据药智数据APP迭代版上线药智数据企业版药智学院